Ocular toxicity and distribution of subconjunctival and intravitreal rapamycin in horses

Journal of Veterinary Pharmacology and Therapeutics

Volumn 31, Issue 6, 2008, Pages 511-516

  Douglas, L C ^a   Yi, N Y ^a   Davis, J L ^a   Salmon, J H ^a   Gilger, B C ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG DETERMINATION; DRUG EFFECT; ELECTRORETINOGRAM; EYE TOXICITY; HISTOPATHOLOGY; HORSE; NONHUMAN; PHOTOSENSITIVITY; PHOTOTOXICITY; PRIORITY JOURNAL; VITREOUS BODY;

ANIMALS; ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DERMATITIS, PHOTOTOXIC; HORSES; SIROLIMUS; TISSUE DISTRIBUTION; UVEITIS;

EQUIDAE;

EID: 55949121603     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2008.00986.x     Document Type: Article

References (21)

1. American Horse Council (2005) National Economic Impact of the U.S. Horse Industry. In National Economic Impact of the U.S. Horse Industry. http://www.horsecouncil.org/statistics.htm
2. Baath, J., Ells, A.L., Crichton, A., Kherani, A. Williams, R.G. (2007) Safety profile of intravitreal triamcinolone acetonide. Journal of Ocular Pharmacology and Therapeutics, 23, 304 310.
3. Deeg, C.A., Ehrenhofer, M., Thurau, S.R., Reese, S., Wildner, G. Kaspers, B. (2002) Immunopathology of recurrent uveitis in spontaneously diseased horses. Experimental Eye Research, 75, 127 133.
4. Deeg, C.A., Amann, B., Raith, A.J. Kaspers, B. (2006) Inter- and intramolecular epitope spreading in equine recurrent uveitis. Investigative Ophthalmology and Visual Science, 47, 652 656.
5. Dwyer, A.E. Gilger, B.C. (2005) Equine recurrent uveitis. In Equine Ophthalmology. Ed. Gilger, B.C, pp. 42 62. Elsevier, Philadelphia.
6. Gilger, B.C. Michau, T.M. (2004) Equine recurrent uveitis: new methods of management. Veterinary Clinics of North America. Equine Practice, 20, 417 427.
7. Gilger, B.C., Malok, E., Cutter, K.V., Stewart, T., Horohov, D.W. Allen, J.B. (1999) Characterization of T-lymphocytes in the anterior uvea of eyes with chronic equine recurrent uveitis. Veterinary Immunology and Immunopathology, 71, 17 28.
8. Gilger, B.C., Salmon, J.H., Wilkie, D.A., Cruysberg, L.P., Kim, J., Hayat, M., Kim, H., Kim, S., Yuan, P., Lee, S.S., Harrington, S.M., Murray, P.R., Edelhauser, H.F., Csaky, K.G. Robinson, M.R. (2006) A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis. Investigative Ophthalmology and Visual Science, 47, 2596 2605.
9. Gilger, B.C., Salmon, J.H., Yi, N.Y., Barden, C.A., Chandler, H.L., Wendt, J. Colitz, C.M. (2008). Role of bacteria in recurrent uveitis in eyes of horses from Southeastern United States. American Journal of Veterinary Research, In press.
10. Komaromy, A.M., Andrew, S.E., Sapp, H.L. Jr., Brooks, D.E. Dawson, W.W. (2003) Flash electroretinography in standing horses using the DTL microfiber electrode. Veterinary Ophthalmology, 6, 27 33.
11. Kulkarni, P. (2001) Review: uveitis and immunosuppressive drugs. Journal of Ocular Pharmacology, 17, 181 187.
12. MacDonald, A., Scarola, J., Burke, J.T. Zimmerman, J.J. (2000) Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus. Clinical Therapeutics, 22 (Suppl B B101 B121.
13. Manzano, R., Peyman, G., Khan, P. et al. (2006) Intravitreal toxicity of rapamycin. Presented at the Association for Research in Vision and Ophthalmology Annual Meeting, Ft, Lauderdale, Florida, USA.
14. Napoli, K.L. Kahan, B.D. (1994) Sample clean-up and high-performance liquid chromatographic techniques for measurement of whole blood rapamycin concentrations. Journal of Chromatography. B, Biomedical Applications, 654, 111 120.
15. Perry, I. Neuberger, J. (2005) Immunosuppression: towards a logical approach in liver transplantation. Clinical and Experimental Immunology, 139, 2 10.
16. Sehgal, S. (1998) Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clinical Biochemistry, 31, 335 340.
17. Shanmuganathan, V., Casely, E., Raj, D., Powell, R.J., Joseph, A., Amoaku, W.M. Dua, H.S. (2005) The efficacy of sirolimus in the treatment of patients with refractory uveitis. British Journal of Ophthalmology, 89, 666 669.
18. Shi, W., Gao, H., Xie, L. Wang, S. (2006) Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits. Investigative Ophthalmology and Visual Science, 47, 3339 3344.
19. Trepanier, D., Gallant, H., Legatt, D. Yatscoff, R. (1998) Rapamycin: distribution, pharmacokinetics and therapeutic range investigations: an update. Clinical Biochemistry, 31, 345 351.
20. Yi, N., Salmon, J., Davis, D. Gilger, B. (2008) Ocular distribution and toxicity of intravitreal triamcinolone acetonide in normal horses. Veterinary Ophthalmology, In press.
21. Zheng, Y., Collins, S.L., Lutz, M.A., Allen, A.N., Kole, T.P., Zarek, P.E. Powell, J.D. (2007) A role for mammalian target of rapamycin in regulating T cell activation versus anergy. Journal of Immunology, 178, 2163 2170.